Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme

BMJ Open

Volumn 6, Issue 8, 2016, Pages

  Babineaux, S M ^a   Curtis, B ^a   Holbrook, T ^b   Milligan, G ^b   Piercy, J ^b  

^a ELI LILLY AND COMPANY   (United States)

^b ADELPHI REAL WORLD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; AGED; BLOOD PRESSURE; BODY MASS; CHINA; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT-REPORTED OUTCOME; PHYSICIAN; QUESTIONNAIRE; REPRODUCIBILITY; SMOKING; UNITED KINGDOM;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CHINA; CHOLESTEROL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT REPORTED OUTCOME MEASURES; PHYSICIANS; REPRODUCIBILITY OF RESULTS; SMOKING; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 85029158054     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/BMJOPEN-2015-010352     Document Type: Article

References (19)

1. IDF Diabetes Atlas Sixth Edition, update 2014. http://www.idf.org/atlasmap/atlasmap?indicator=i1&date=2014 (accessed 28 May 2015).
2. National Diabetes Research Group. A mass survey of diabetes mellitus in a population of 300, 000 in 14 provinces and municipalities in China (author's transl). Zhonghua Nei Ke Za Zhi 1981;20:678-83.
3. Diabetes in China: mapping the road ahead. Lancet Diabetes Endocrinol 2014;2:923.
4. Saunders C, Byrne CD, Guthrie B, et al. Scottish Diabetes Research Network Epidemiology Group. External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med 2013;30:300-8.
5. Ruokoniemi P, Sund R, Arffman M, et al. Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland. BMJ Open 2014;4:e005402.
6. Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific Programmes-a means to understand. Curr Med Res Opin 2008;24:3063-72.
7. EphMRA Code of Conduct. Updated January 2016. http://www.ephmra.org/code-of-conduct/2/A-Purpose-Scope-and-Sources (accessed 21 Apr 2016).
8. US Department of Health and Human Services. Summary of the HIPAA Privacy Rule May 2003. http://www.hhs.gov/sites/default/files/privacysummary.pdf (accessed 21 Apr 2016).
9. Ji LN, Lu JM, Guo XH, et al. Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health 2013;13:602.
10. Health and Social Care Information Centre. Health Survey for England-2011, health, social care and lifestyles. 20 Dec 2012. http://www.hscic.gov.uk/catalogue/PUB09300 (accessed 28 May 2015).
11. Health and Social Care Information Centre. Health Survey for England-2011, health, social care and lifestyles. List of variables. Version 1. http://doc.ukdataservice.ac.uk/doc/7260/mrdoc/pdf/7260datadocs.pdf (accessed 28 May 2015).
12. Health and Social Care Information Centre. Health Survey for England-2011. Volume 2 Methods and documentation. 2012. http://www.hscic.gov.uk/catalogue/PUB09300/HSE2011-Methods-and-docs.pdf (accessed 28 May 2015).
13. Schuirmann DA. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Pharmacometrics 1987;15:657-80.
14. Chow S-C, Shaeo J, Wang H, eds. Sample size calculations in clinical research. ISBN 0-8247-0970-5. New York (NY): Marcel Dekker, 2003:13.
15. Bi Y, Zhu D, Cheng J, et al. The status of glycemic control: a cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther 2010;32:973-83.
16. Ji L, Li H, Guo X, et al. Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial. PLoS One 2013;8:e57222.
17. Guo XH, Yuan L, Lou QQ, et al. Chinese Diabetes Education Status Survey Study Group. A nationwide survey of diabetes education, self-management and glycemic control in patients with type 2 diabetes in China. Chin Med J (Engl) 2012;125:4175-80.
18. NHS Diabetes Working Group. Self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. 2010. http://webarchive.nationalarchives.gov.uk/20130513172055/http:/www.diabetes.nhs.uk/document.php?o=238 (accessed 28 May 2015).
19. Yasky J, Verho M, Erasmus TP, et al. Efficacy of ramipril versus enalapril in patients with mild to moderate essential hypertension. Br J Clin Pract 1996;50:302-10.